Ticagrelor and Peripheral Arterial Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gerardo Rodriguez, MD PhD
Arkansas Heart Hospital
Study Director - Hinan Ahmed, MD
University Of Texas Health Science Center in San Antonio
Principal Investigator - Marc D Feldman, MD
University Of Texas Health Science Center in San Antonio
Principal Investigator - Massoud Leesar, MD
University of Alabama at Birmingham
Principal Investigator - Mehmet Cilingiroglu, MD
Arkansas Heart Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Heart Hospital
Little Rock, Arkansas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2015
- Primary completion
- 17 Jan 2017
- Completion
- 17 Jan 2017
- Last update posted
- 11 Jan 2019
- Registered enrollment
- 26
- Registry id
- NCT02407314
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.